Beyond the proprietary and exclusive technology used to stabilize rice bran, seven U.S. patents have been awarded based on NutraCea research into the nutritional properties of rice bran. Patents include methods for treating hypercholesterolemia, hyperlipidemia, atherosclerosis, and controlling serum glucose; and, treatments for joint inflammation, pain and loss of mobility.

Research into rice bran and its derivatives continues at NutraCea to better understand the value SRB brings to our market segments as a food ingredient and a nutritional aid.

1. "Process for Obtaining Micronutrient Enriched Rice Bran Oil" —November 16, 1999

   32 Claims: A simple and effective method for obtaining enriched micronutrients from rice bran oil.

2. "Method for Treating Hypercholesterolemia, Hyperlipidemia, and Atherosclerosis" —October 3, 2000

   25 Claims: Stabilized rice bran derivatives effectively reduce serum lipids and cholesterol and prevent heart disease.

3. "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" —October 16, 2001

   11 Claims: Stabilized rice bran derivatives normalize glucose levels in hyperglycemic and hypoglycemic subjects.

4. "Method for Controlling Serum Glucose" —February 26, 2002

   22 Claims: Stabilized rice bran derivatives effectively reduce serum glucose levels and glycosylated hemoglobin in diabetic subjects.

5. "Method for Treating Hypercholesterolemia, Hyperlipidemia, and Atherosclerosis" —May 6,2003

   13 Claims: A process of enzymatic treatment of Stabilized rice bran to obtain RiSolubles and RiceMucil.

6. "Method for Treating Hypercholesterolemia, Hyperlipidemia, and Atherosclerosis" —May 11, 2004

   20 Claims: A method for inhibiting platelet aggregation, inhibiting HMG CoA reductase and reducing the cardiovascular disease risks in a mammal.

7. "Method for Treating Joint Inflammation, Pain, and Loss of Mobility" —June 7, 2005

   11 Claims: Methods and formulations for treating an inflammatory disease or reducing inflammatory reaction in all mammals, inhibiting prostaglandin synthetase activity and a method for treating pain, lameness or loss of mobility in a mammal.